XSHE
300313
Market cap437mUSD
Oct 09, Last price
13.11CNY
1D
7.37%
1Q
55.89%
Jan 2017
-31.00%
IPO
76.75%
Name
Xinjiang Tianshan Animal Husbandry Bio-Engineering Co Ltd
Chart & performance
P/E
—
P/S
15.70
EPS
—
Div yield, %
—
Shrs. gr., 5y
0.25%
Rev. gr., 5y
13.15%
Revenues
200m
+45.53%
Net income
-27m
L-58.78%
CFO
5m
-66.46%
Dividend
May 08, 20150.05 CNY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Xinjiang Tianshan Animal Husbandry Bio-engineering Co., Ltd. (300313.SZ) is a Chinese enterprise primarily focused on cattle and sheep farming. The company utilizes advanced biological genetic technology to enhance livestock breeds, supplying embryos, other genetic resources, and relevant services to the animal husbandry sector. Furthermore, its operations span the complete beef production chain, including breeding, fattening, slaughtering, processing, and marketing beef cattle, alongside the processing of mutton products. Founded in 2003, the company is headquartered in Changji, China.
Key people
Caiyuan Lin
President · since 2025
Yuefan Chen
Chief Financial Officer · since 2022
Jie Chen
Vice President, Director · since 2025
Jianjun Ge
Vice President · since 2025
Qiang Li
Vice President, Director · since 2025
Minghui Han
Deputy General Manager, Secretary of the Board, Director · since 2023
Jidong Chen
Independent Director · since 2025
Kaihui Li
Independent Director · since 2025
Independent Director · since 2025
Xinzhong Wu
Independent Director · since 2020
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2023‑00 | 2022‑12 | 2022‑00 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||||
Revenues | ||||||||||||
Cost of revenue | ||||||||||||
Unusual Expense (Income) | ||||||||||||
NOPBT | ||||||||||||
NOPBT Margin | ||||||||||||
Operating Taxes | ||||||||||||
Tax Rate | ||||||||||||
NOPAT | ||||||||||||
Net income | ||||||||||||
Dividends | ||||||||||||
Dividend yield | ||||||||||||
Proceeds from repurchase of equity | ||||||||||||
BB yield | ||||||||||||
| Debt | ||||||||||||
Debt current | ||||||||||||
Long-term debt | ||||||||||||
Deferred revenue | ||||||||||||
Other long-term liabilities | ||||||||||||
Net debt | ||||||||||||
| Cash flow | ||||||||||||
Cash from operating activities | ||||||||||||
CAPEX | ||||||||||||
Cash from investing activities | ||||||||||||
Cash from financing activities | ||||||||||||
FCF | ||||||||||||
| Balance | ||||||||||||
Cash | ||||||||||||
Long term investments | ||||||||||||
Excess cash | ||||||||||||
Stockholders' equity | ||||||||||||
Invested Capital | ||||||||||||
ROIC | ||||||||||||
ROCE | ||||||||||||
| EV | ||||||||||||
Common stock shares outstanding | ||||||||||||
Price | ||||||||||||
Market cap | ||||||||||||
EV | ||||||||||||
EBITDA | ||||||||||||
EV/EBITDA | ||||||||||||
Interest | ||||||||||||
Interest/NOPBT | ||||||||||||